Variant report

Variant	esv3370617
Chromosome Location	chr17:45329978-45332826
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:425)
CpG islands
(count:427)
Chromatin interactive
region (count:4)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:425 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr17:45331247-45331392	K562	blood:	n/a	n/a
2	ATF2	chr17:45331195-45331504	GM12878	blood:	n/a	n/a
3	BACH1	chr17:45330939-45332149	H1-hESC	embryonic stem cell:	n/a	n/a
4	BCLAF1	chr17:45330999-45331648	GM12878	blood:	n/a	chr17:45331564-45331577 chr17:45331567-45331576 chr17:45331565-45331578 chr17:45331562-45331575 chr17:45331208-45331221
5	BHLHE40	chr17:45331112-45331659	GM12878	blood:	n/a	chr17:45331446-45331462
6	BHLHE40	chr17:45331215-45331402	K562	blood:	n/a	n/a
7	BRCA1	chr17:45330656-45330710	Hela-S3	cervix:	n/a	n/a
8	BRCA1	chr17:45331392-45331399	HepG2	liver:	n/a	n/a
9	BRCA1	chr17:45329710-45330212	HepG2	liver:	n/a	n/a
10	CBX3	chr17:45331081-45331471	K562	blood:	n/a	n/a
11	CCNT2	chr17:45331060-45331801	K562	blood:	n/a	n/a
12	CEBPB	chr17:45330569-45330810	H1-hESC	embryonic stem cell:	n/a	n/a
13	CEBPB	chr17:45330490-45330782	K562	blood:	n/a	n/a
14	CEBPB	chr17:45330624-45330658	Hela-S3	cervix:	n/a	n/a
15	CEBPB	chr17:45330559-45330759	HepG2	liver:	n/a	n/a
16	CEBPB	chr17:45330487-45330750	ECC-1	luminal epithelium:	n/a	n/a
17	CHD1	chr17:45331162-45331698	GM12878	blood:	n/a	n/a
18	CHD2	chr17:45331327-45331341	HepG2	liver:	n/a	n/a
19	CHD2	chr17:45331302-45331410	Hela-S3	cervix:	n/a	n/a
20	CHD2	chr17:45331341-45331410	H1-hESC	embryonic stem cell:	n/a	n/a
21	CREB1	chr17:45331096-45331589	H1-hESC	embryonic stem cell:	n/a	n/a
22	CREB1	chr17:45331040-45331495	A549	lung:	n/a	n/a
23	CTBP2	chr17:45330800-45332290	H1-hESC	embryonic stem cell:	n/a	n/a
24	CTCF	chr17:45330320-45330470	RPTEC	kidney:	n/a	n/a
25	CTCF	chr17:45331220-45331370	GM12874	blood:	n/a	n/a
26	CTCF	chr17:45331200-45331350	GM12871	blood:	n/a	n/a
27	CTCF	chr17:45331280-45331430	BJ	skin:	n/a	n/a
28	CTCF	chr17:45331220-45331370	AG09309	skin:	n/a	n/a
29	CTCF	chr17:45330320-45330470	SK-N-SH_RA	brain:	n/a	n/a
30	CTCF	chr17:45331126-45331446	GM12892	blood:	n/a	n/a
31	CTCF	chr17:45331040-45331190	BJ	skin:	n/a	n/a
32	CTCF	chr17:45331163-45331365	A549	lung:	n/a	n/a
33	CTCF	chr17:45331200-45331350	GM12865	blood:	n/a	n/a
34	CTCF	chr17:45331280-45331430	MCF-7	breast:	n/a	n/a
35	CTCF	chr17:45331200-45331350	GM12869	blood:	n/a	n/a
36	CTCF	chr17:45331141-45331462	MCF-7	breast:	n/a	n/a
37	CTCF	chr17:45330440-45330590	HBMEC	blood vessel:	n/a	n/a
38	CTCF	chr17:45331200-45331350	HFF	foreskin:	n/a	n/a
39	CTCF	chr17:45331240-45331390	HUVEC	blood vessel:	n/a	n/a
40	CTCF	chr17:45331200-45331350	HPAF	blood vessel:	n/a	n/a
41	CTCF	chr17:45331900-45332050	HCPEpiC	choroid plexus:	n/a	chr17:45331927-45331936 chr17:45331921-45331939
42	CTCF	chr17:45330460-45330610	GM12872	blood:	n/a	n/a
43	CTCF	chr17:45331197-45331354	GM20000	blood:	n/a	n/a
44	CTCF	chr17:45331240-45331390	HEK293	kidney:	n/a	n/a
45	CTCF	chr17:45331154-45331412	LNCaP	prostate:	n/a	n/a
46	CTCF	chr17:45331220-45331370	GM12878	blood:	n/a	n/a
47	CTCF	chr17:45331220-45331370	HMF	breast:	n/a	n/a
48	CTCF	chr17:45331137-45331433	MCF-7	breast:	n/a	n/a
49	CTCF	chr17:45331220-45331370	GM12864	blood:	n/a	n/a
50	CTCF	chr17:45331163-45331397	Gliobla	brain:	n/a	n/a

(count:427 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:45331061-45331111	NT2-D1	testis:	n/a
2	chr17:45330929-45330979	PrEC	prostate:	n/a
3	chr17:45330862-45330912	HCF	heart:	n/a
4	chr17:45331082-45331132	HCPEpiC	choroid plexus:	n/a
5	chr17:45331061-45331111	IMR90	lung:	fetal
6	chr17:45330862-45330912	H1-hESC	embryonic stem cell:	embryo
7	chr17:45332022-45332072	PANC-1	pancreas:	n/a
8	chr17:45331354-45331404	HPAEpiC	pulmonary alveolar:	n/a
9	chr17:45330862-45330912	AoSMC	blood vessel:	n/a
10	chr17:45331082-45331132	BJ	skin:	n/a
11	chr17:45331354-45331404	Jurkat	blood:	n/a
12	chr17:45330878-45330928	HEEpiC	esophagus:	n/a
13	chr17:45332022-45332072	AG04450	lung:	fetal
14	chr17:45331061-45331111	ECC-1	luminal epithelium:	n/a
15	chr17:45331354-45331404	HRE	kidney:	n/a
16	chr17:45331082-45331132	HCF	heart:	n/a
17	chr17:45330929-45330979	SK-N-SH_RA	brain:	n/a
18	chr17:45330862-45330912	SK-N-SH_RA	brain:	n/a
19	chr17:45330878-45330928	U87	brain:	n/a
20	chr17:45331354-45331404	AG04450	lung:	fetal
21	chr17:45330929-45330979	GM19239	blood:	n/a
22	chr17:45330862-45330912	T-47D	breast:	n/a
23	chr17:45330929-45330979	BE2_C	brain:	n/a
24	chr17:45331354-45331404	SK-N-SH_RA	brain:	n/a
25	chr17:45331082-45331132	ProgFib	skin:	n/a
26	chr17:45330929-45330979	Caco-2	colon:	n/a
27	chr17:45331061-45331111	H1-hESC	embryonic stem cell:	embryo
28	chr17:45331354-45331404	HRCEpiC	kidney:	n/a
29	chr17:45331061-45331111	NHBE	bronchial:	n/a
30	chr17:45331082-45331132	SK-N-SH	brain:	n/a
31	chr17:45332022-45332072	HRPEpiC	eye:	n/a
32	chr17:45331082-45331132	GM12892	blood:	n/a
33	chr17:45330929-45330979	MCF10A-Er-Src	breast:	n/a
34	chr17:45330878-45330928	HRCEpiC	kidney:	n/a
35	chr17:45332022-45332072	GM12892	blood:	n/a
36	chr17:45330929-45330979	HPAEpiC	pulmonary alveolar:	n/a
37	chr17:45331354-45331404	K562	blood:	n/a
38	chr17:45331061-45331111	SK-N-SH_RA	brain:	n/a
39	chr17:45331082-45331132	HUVEC	blood vessel:	n/a
40	chr17:45330862-45330912	HCPEpiC	choroid plexus:	n/a
41	chr17:45331082-45331132	HepG2	liver:	n/a
42	chr17:45331082-45331132	NHDF-neo	bronchial:	n/a
43	chr17:45331354-45331404	HEK293	kidney:	embryo
44	chr17:45330929-45330979	HCF	heart:	n/a
45	chr17:45330929-45330979	AG10803	skin:	n/a
46	chr17:45331354-45331404	HCM	heart:	n/a
47	chr17:45330878-45330928	BJ	skin:	n/a
48	chr17:45332022-45332072	ProgFib	skin:	n/a
49	chr17:45330878-45330928	PANC-1	pancreas:	n/a
50	chr17:45332022-45332072	AoSMC	blood vessel:	n/a

(count:4 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:45326928..45330471-chr17:45335403..45338279,3	K562	blood:
2	chr17:45331567..45334832-chr17:45348369..45350446,3	K562	blood:
3	chr17:45297983..45300898-chr17:45329772..45332242,2	K562	blood:
4	chr17:45332159..45334737-chr17:45364459..45366214,2	K562	blood:

No data

Variant related genes	Relation type
ENSG00000259753	TF binding region
ITGB3	TF binding region
ENSG00000259753	CpG island
ITGB3	CpG island
ENSG00000238419	chromatin interactions
ENSG00000252088	chromatin interactions

Extended variants
information (count: 110 )
Associated
traits (count: 118 )

Variant overlapped rSNPs/rCNVs (count:110 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs574721735	chr17:45330059-45330060	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
2	rs3809861	chr17:45330066-45330067	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs111877585	chr17:45330073-45330074	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
4	rs532529722	chr17:45330116-45330117	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
5	rs371528641	chr17:45330132-45330133	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
6	rs60376770	chr17:45330138-45330139	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
7	rs11651862	chr17:45330142-45330143	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
8	rs559700701	chr17:45330176-45330177	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
9	rs528731759	chr17:45330201-45330202	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
10	rs140405990	chr17:45330228-45330229	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
11	rs144159526	chr17:45330242-45330243	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
12	rs531035318	chr17:45330337-45330338	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
13	rs549842684	chr17:45330372-45330373	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
14	rs569687909	chr17:45330399-45330400	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
15	rs147363351	chr17:45330408-45330409	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
16	rs3809862	chr17:45330428-45330429	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
17	rs368718337	chr17:45330433-45330434	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
18	rs534902286	chr17:45330512-45330513	Bivalent Enhancer Enhancers Weak transcription Active TSS	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs554932811	chr17:45330611-45330612	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs563095208	chr17:45330654-45330655	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs574683182	chr17:45330678-45330679	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs34394910	chr17:45330698-45330699	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs76780584	chr17:45330708-45330709	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs70940818	chr17:45330715-45330716	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs557129367	chr17:45330745-45330746	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs577222311	chr17:45330751-45330752	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs546299881	chr17:45330752-45330753	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs7208170	chr17:45330759-45330760	Bivalent Enhancer Enhancers Active TSS Bivalent/Poised TSS Flanking Active TSS Weak transcription Flanking Bivalent TSS/Enh	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
29	rs62074393	chr17:45330802-45330803	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs7208055	chr17:45330827-45330828	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
31	rs193210750	chr17:45330828-45330829	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
32	rs115826301	chr17:45330924-45330925	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs550852610	chr17:45330930-45330931	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs550664109	chr17:45331010-45331011	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs12940693	chr17:45331057-45331058	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs373078923	chr17:45331082-45331083	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs55827077	chr17:45331083-45331084	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs532077721	chr17:45331092-45331093	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region CpG island Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs567581451	chr17:45331136-45331137	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
40	rs566454077	chr17:45331168-45331169	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
41	rs117052258	chr17:45331221-45331222	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
42	rs1051430	chr17:45331262-45331263	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
43	rs115600591	chr17:45331267-45331268	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
44	rs534654534	chr17:45331284-45331285	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
45	rs548495900	chr17:45331285-45331286	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
46	rs273585614	chr17:45331312-45331313	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
47	rs373747142	chr17:45331335-45331336	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
48	rs568320937	chr17:45331343-45331344	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
49	rs546665111	chr17:45331350-45331351	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
50	rs11871407	chr17:45331358-45331359	Bivalent/Poised TSS Active TSS Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Bivalent Enhancer Transcr. at gene 5' and 3'	Chromatin interactive region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:118)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Melanoma	18172304	CNVD
Moyamoya disease	22323933	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Ovarian cancer	21781307	CNVD
Colorectal cancer	21645411	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Medulloblastoma	21979893	CNVD
Cancer	20164919	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Hodgkin''s lymphoma	17606441	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell lymphomas	19863542	CNVD
Cancer	16751803	CNVD
Chordoma	21602918	CNVD
Neurofibromatosis	20686819	CNVD
Peripheral nerve sheath tumors	20686819	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Cancer	21499728	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	17897457	CNVD
Neuroblastoma	17327916	CNVD
Breast cancer	21264507	CNVD
Endometrial cancer	22040021	CNVD
Neuroblastoma	21484798	CNVD
Breast cancer	22028636	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute myeloid leukemia	20724749	CNVD
Breast cancer	21858162	CNVD
lymphocytic leukemia	21291569	CNVD
Gastric cancer	17167181	CNVD
Breast cancer	19287154	CNVD
Leukemia	20874852	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Neuroblastoma	18664255	CNVD
Neuroblastoma	17533364	CNVD
Human rectal carcinomas	16397240	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Breast cancer	17457667	CNVD
Breast cancer	16951389	CNVD
Basal cell lymphoma	17053054	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22048815	CNVD
Breast cancer	17603634	CNVD
Follicular lymphoma	20505157	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Cervical cancer	21062161	CNVD
Breast cancer	20953835	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	17443227	CNVD
Hirschsprung''s Disease	21712996	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
TAR Syndrome	17847015	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	17850661	CNVD
Breast cancer	19261255	CNVD
Lung cancer	16773561	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Basal-like breast cancer	18066063	CNVD
Breast cancer	20031965	CNVD
Colorectal cancer	19287155	CNVD
Hereditary breast	19566914	CNVD
Ovarian cancer	19047089	CNVD
Ovarian cancer	19566914	CNVD
Triple-negative breast cancer	18950515	CNVD
Breast cancer	16846527	CNVD
Bladder cancer	21909424	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Acute myeloid leukemia	21251322	CNVD
Ewing''s sarcoma	22429812	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Breast cancer	21364760	CNVD
Breast cancer	21509527	CNVD
Urothelial carcinoma	21177765	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Breast cancer	17142309	CNVD
Breast cancer	16397240	CNVD
Ovarian clear cell carcinoma	19293255	CNVD
Myelofibrosis	22110671	CNVD
Prostate cancer	17217626	CNVD
Non-syndromic sensorineural hearing loss	21084979	CNVD
Autism	22817714	CNVD
Breast cancer	20409316	CNVD
Cancer	17160897	CNVD
Frontotemporal lobar degeneration	19640594	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Ovarian clear cell carcinoma	21343371	CNVD

Chromatin state (count:447 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:45314200-45330200	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
2	chr17:45318600-45330600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
3	chr17:45318600-45331200	Weak transcription	HSMMtube	muscle
4	chr17:45323000-45330600	Weak transcription	Sigmoid Colon	Sigmoid Colon
5	chr17:45326800-45330800	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
6	chr17:45328200-45330400	Weak transcription	Adipose Nuclei	Adipose
7	chr17:45328600-45330200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
8	chr17:45328600-45330200	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
9	chr17:45328600-45330600	Enhancers	Fetal Intestine Small	intestine
10	chr17:45328600-45330600	Enhancers	K562	blood
11	chr17:45328600-45330800	Enhancers	Rectal Mucosa Donor 31	rectum
12	chr17:45328800-45332200	Enhancers	Fetal Heart	heart
13	chr17:45329000-45330800	Enhancers	Fetal Intestine Large	intestine
14	chr17:45329400-45330200	Bivalent Enhancer	HUES64 Cell Line	embryonic stem cell
15	chr17:45329400-45330200	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
16	chr17:45329400-45330400	Bivalent Enhancer	ES-WA7 Cell Line	embryonic stem cell
17	chr17:45329400-45330400	Flanking Active TSS	HepG2	liver
18	chr17:45329400-45330600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
19	chr17:45329400-45330800	Enhancers	Placenta	Placenta
20	chr17:45329400-45331200	Enhancers	Liver	Liver
21	chr17:45329600-45330000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
22	chr17:45329600-45330000	Bivalent Enhancer	H9 Cell Line	embryonic stem cell
23	chr17:45329600-45330000	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
24	chr17:45329600-45330200	Enhancers	Left Ventricle	heart
25	chr17:45329600-45330400	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
26	chr17:45329600-45330600	Bivalent Enhancer	iPS-15b Cell Line	embryonic stem cell
27	chr17:45329600-45330600	Enhancers	NHDF-Ad	bronchial
28	chr17:45329600-45330800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
29	chr17:45329600-45330800	Bivalent Enhancer	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
30	chr17:45329600-45330800	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr17:45329600-45330800	Enhancers	Aorta	Aorta
32	chr17:45329600-45330800	Enhancers	Right Ventricle	heart
33	chr17:45329800-45330600	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
34	chr17:45329800-45330800	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
35	chr17:45329800-45330800	Bivalent Enhancer	HUES6 Cell Line	embryonic stem cell
36	chr17:45329800-45330800	Enhancers	Duodenum Mucosa	Duodenum
37	chr17:45329800-45330800	Weak transcription	Ovary	ovary
38	chr17:45329800-45330800	Weak transcription	Right Atrium	heart
39	chr17:45329800-45330800	Enhancers	Hela-S3	cervix
40	chr17:45330200-45330400	Bivalent Enhancer	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
41	chr17:45330200-45330400	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr17:45330200-45330800	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
43	chr17:45330200-45330800	Weak transcription	Left Ventricle	heart
44	chr17:45330400-45330600	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
45	chr17:45330400-45330600	Enhancers	Adipose Nuclei	Adipose
46	chr17:45330400-45330600	Bivalent Enhancer	Dnd41	blood
47	chr17:45330400-45330800	Enhancers	Primary B cells from peripheral blood	blood
48	chr17:45330400-45330800	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
49	chr17:45330400-45330800	Active TSS	Fetal Muscle Trunk	muscle
50	chr17:45330400-45330800	Bivalent Enhancer	Fetal Stomach	stomach

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links